Manager, Lab, CCI Technology
June 08, 2020
To meet this challenge, West experts work with customers to develop programs that are tailored to their packaging and delivery systems, at any phase of drug development. In the early phases, West offers theoretical stack up calculations, capping services, residual seal force testing, and helium leak testing capabilities that can be used to understand proper component fit. In the later phases, West offers testing and analysis utilizing numerous CCI technologies as outlined in USP <1207> Package Integrity Evaluation – Sterile Products. Since no one CCI technology works for all systems, West’s CCI group utilizes several:
- tracer gas leak detection (helium)
- headspace analysis (oxygen, carbon dioxide, water, pressure)
- high voltage leak detection
- vacuum decay
- dye ingress
And to maximize use of these technologies, West employs custom fixtures (patent pending). An example of West’s capabilities was recently published: Long-Term Study of Container Closure Integrity of Rubber–Glass Vial Systems by Multiple Methods in the PDA Journal of Pharmaceutical Science and Technology, 74, 147-161 (2020). This type of support is a key aspect of West’s commitment to the safe and efficient delivery of drug products.
Simplify the Journey™ is a trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.